Yukihiro Shiga Selected Research

Yukihiro Shiga Research Topics

20	Glaucoma 01/2021 - 06/2013
6	Ganglion Cysts (Ganglion) 10/2020 - 11/2013
5	Low Tension Glaucoma 09/2017 - 12/2014
4	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2021 - 01/2017
3	Inflammation (Inflammations) 12/2021 - 01/2017
3	Hyperoxia 09/2020 - 01/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 01/2014
3	Blister (Bulla) 12/2019 - 02/2015
2	Retinal Vein Occlusion 01/2020 - 01/2014
2	Cicatrix (Scar) 12/2019 - 02/2015
1	Neuroinflammatory Diseases 12/2021
1	Neoplasms (Cancer) 09/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2020
1	Ischemia 01/2020
1	Reperfusion Injury 01/2020
1	Genetic Risk Score 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Bradycardia 05/2018
1	Atrophy 05/2018
1	Optic Nerve Injuries 06/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2014
1	Macular Edema 01/2014

10	Retinaldehyde (Retinal)IBA 12/2021 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 09/2020 - 02/2016
3	HesperidinIBA 12/2021 - 01/2017
2	N-Methylaspartate (NMDA)IBA 12/2021 - 01/2017
2	Neuroprotective AgentsIBA 12/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2014
2	AntioxidantsIBA 01/2021 - 01/2017
2	Oxygen (Dioxygen)IBA 09/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2019
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2019 - 01/2019
2	tafluprostIBA 01/2017 - 06/2013
1	CytokinesIBA 12/2021
1	trans-sodium crocetinate (crocetin)IBA 01/2021
1	TabletsIBA 01/2021
1	RecoverinIBA 09/2020
1	AntibodiesIBA 09/2020
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Amsacrine (AMSA)IBA 12/2019
1	Topoisomerase II InhibitorsIBA 12/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Colchicine FDA LinkGeneric 01/2019
1	SteroidsIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 06/2017
1	Syntex adjuvant formulationIBA 01/2017
1	Biological ProductsIBA 01/2017
1	CalpainIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	rho-Associated KinasesIBA 10/2014
1	K-115IBA 10/2014
1	Bevacizumab (Avastin)FDA Link 01/2014

12	Lasers (Laser) 10/2020 - 01/2014
3	Trabeculectomy (Trabeculoplasty) 12/2019 - 02/2015
1	Filtering Surgery 12/2019
1	Intravitreal Injections 01/2014